Business Context and Reporting Period
Company: BioLife Solutions, Inc. (BLFS)
Filing Type: Form 8-K (Current Report)
Date of Report: November 17, 2025
Reporting Period: Single event date (November 17, 2025)
Business Context: The filing serves as a Regulation FD disclosure to announce the issuance of an investor presentation. The presentation is furnished as Exhibit 99.1 and is available on the company's investor relations website.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the release of an investor presentation rather than a financial statement containing audited or unaudited financial data.
Material Changes
No material changes to financial performance or operations are detailed within the text of this filing. The primary event is the public dissemination of the investor presentation dated November 17, 2025.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates by reference an investor presentation (Exhibit 99.1) which likely contains management commentary, outlook, and guidance, but the specific content of that presentation is not included in the text of this 8-K.
Risks and Contingencies: The filing includes a standard disclaimer stating that the information in Item 7.01 and Exhibit 99.1 is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act. Consequently, this information is not subject to the liabilities of that section nor incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the full text of the Investor Presentation (Exhibit 99.1) available at the provided URL for specific financial guidance and operational updates.
- Verify the "furnished" status of the presentation to understand the legal liability limitations regarding the forward-looking statements contained therein.
- Confirm the date of the presentation (November 17, 2025) aligns with the most recent market expectations.